Harjit Gill – CEO, APACMed

In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a chance to change the global narrative on medtech in healthcare, and the key trends shaping the region’s dynamic market.  
We often use the term “learning and leapfrogging” in Asia-Pacific, meaning that necessity has become a mother to innovation. For example, the rapid adoption of digital health tools that overcome geographic and demographic barriers is perhaps a lesson for the West on how to do more with less
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report